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A 53-year-old woman had multiple bilateral axillary and left supraclavicular lymph-node (LN) enlargements for 6 
months. LN biopsy revealed anaplastic large-cell lymphoma (ALCL) that was anaplastic lymphoma kinase 
(ALK)-negative (A. typical “hallmark” cell: pleomorphic neoplastic lymphoid cells, hematoxylin & eosin stain, ×400). 
A bone marrow (BM) study for staging work-up revealed no evidence of neoplastic lymphoid-cell infiltration. 
Chemotherapy was administered and autologous hematopoietic stem cell transplantation (a-HSCT) was performed. 
O n  d a y  5 5  p o s t  a - H S C T ,  f o l l o w - u p  c o m p l e t e  b l o o d  c e l l  c o unt revealed abnormal findings: hemoglobin level, 9.4 
g/dL; leukocyte count, 13.8×10
3/μL; and platelet count, 26×10
3/μL. Peripheral blood (PB) smear showed small to large 
pleomorphic neoplastic lymphoid cells (B, Wright stain, ×1,000) comprising 23% of the cells in differential counts. 
Subsequent BM study disclosed neoplastic lymphoid cells (6% in BM aspirate) in the BM clot, and the cells showed 
positive results for CD3 and CD30. On day 84 post a-HSCT, the patient’s PB smears revealed leukocytosis; ALCL 
cells comprised over 70-94% of the nucleated cells. Although the small-cell variant of ALK-positive ALCL may be 
typically associated with involvement of PB, our patient showed a rare manifestation of ALK-negative ALCL 
involving PB, with a leukemic phase.